Literature DB >> 18848548

Prevention of the cytopathic effect induced by Clostridium difficile Toxin B by active Rac1.

Ismael Halabi-Cabezon1, Johannes Huelsenbeck, Martin May, Markus Ladwein, Klemens Rottner, Ingo Just, Harald Genth.   

Abstract

Clostridium difficile Toxin B (TcdB) glucosylates low molecular weight GTP-binding proteins of the Rho subfamily and thereby causes actin re-organization (cell rounding). This "cytopathic effect" has been generally attributed to RhoA inactivation. Here we show that cells expressing non-glucosylatable Rac1-Q61L are protected from the cytopathic effect of TcdB. In contrast, cells expressing RhoA-Q63L or mock-transfected cells are fully susceptible for the cytopathic effect of TcdB. These findings are extended to the Rac1/RhoG mimic IpgB1 and the RhoA mimic IpgB2 from Shigella. Ectopic expression of IpgB1, but not IpgB2, counteracts the cytopathic effect of TcdB. These data strongly suggest that Rac1 rather than RhoA glucosylation is critical for the cytopathic effect of TcdB.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18848548     DOI: 10.1016/j.febslet.2008.10.003

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Clostridium perfringens TpeL glycosylates the Rac and Ras subfamily proteins.

Authors:  Masahiro Nagahama; Akiko Ohkubo; Masataka Oda; Keiko Kobayashi; Katsuhiko Amimoto; Kazuaki Miyamoto; Jun Sakurai
Journal:  Infect Immun       Date:  2010-11-22       Impact factor: 3.441

Review 2.  Bacterial factors exploit eukaryotic Rho GTPase signaling cascades to promote invasion and proliferation within their host.

Authors:  Michel R Popoff
Journal:  Small GTPases       Date:  2014-05-08

Review 3.  Clostridium difficile infection: molecular pathogenesis and novel therapeutics.

Authors:  Ardeshir Rineh; Michael J Kelso; Fatma Vatansever; George P Tegos; Michael R Hamblin
Journal:  Expert Rev Anti Infect Ther       Date:  2014-01       Impact factor: 5.091

4.  Enteric glial cells are susceptible to Clostridium difficile toxin B.

Authors:  Katia Fettucciari; Pamela Ponsini; Davide Gioè; Lara Macchioni; Camilla Palumbo; Elisabetta Antonelli; Stefano Coaccioli; Vincenzo Villanacci; Lanfranco Corazzi; Pierfrancesco Marconi; Gabrio Bassotti
Journal:  Cell Mol Life Sci       Date:  2016-11-28       Impact factor: 9.261

5.  Clostridium difficile toxin A attenuates Wnt/β-catenin signaling in intestinal epithelial cells.

Authors:  Bruno Bezerra Lima; Bárbara Faria Fonseca; Nathália da Graça Amado; Débora Moreira Lima; Ronaldo Albuquerque Ribeiro; José Garcia Abreu; Gerly Anne de Castro Brito
Journal:  Infect Immun       Date:  2014-04-07       Impact factor: 3.441

6.  Difference in the biological effects of Clostridium difficile toxin B in proliferating and non-proliferating cells.

Authors:  Marta Lica; Florian Schulz; Ilona Schelle; Martin May; Ingo Just; Harald Genth
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2011-01-07       Impact factor: 3.000

7.  Actin re-organization induced by Chlamydia trachomatis serovar D--evidence for a critical role of the effector protein CT166 targeting Rac.

Authors:  Jessica Thalmann; Katrin Janik; Martin May; Kirsten Sommer; Jenny Ebeling; Fred Hofmann; Harald Genth; Andreas Klos
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

Review 8.  The enterotoxicity of Clostridium difficile toxins.

Authors:  Xingmin Sun; Tor Savidge; Hanping Feng
Journal:  Toxins (Basel)       Date:  2010-07-14       Impact factor: 4.546

9.  Actin-dependent activation of serum response factor in T cells by the viral oncoprotein tip.

Authors:  Kristin Katsch; Sarah Jill de Jong; Jens-Christian Albrecht; Julia Steger; Harald Genth; Guido Posern; Brigitte Biesinger
Journal:  Cell Commun Signal       Date:  2012-03-03       Impact factor: 5.712

10.  Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.

Authors:  Martin May; Tianbang Wang; Micro Müller; Harald Genth
Journal:  Toxins (Basel)       Date:  2013-01-11       Impact factor: 4.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.